Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Asset Writedowns and Impairment (2016 - 2020)

Surgery Partners' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $74.4 million for Q4 2018.

  • For Q4 2018, Asset Writedowns and Impairment changed N/A year-over-year to $74.4 million; the TTM value through Dec 2021 reached $86.0 million, down 8.71%, while the annual FY2020 figure was $33.5 million, 324.05% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2018 was $74.4 million at Surgery Partners, up from $11.6 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $74.4 million in Q4 2018 and bottomed at $3.5 million in Q2 2016.
  • The 5-year median for Asset Writedowns and Impairment is $5.8 million (2015), against an average of $10.9 million.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 47.69% in 2015 before it dropped 29.44% in 2016.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $5.1 million in 2014, then skyrocketed by 47.69% to $7.5 million in 2015, then increased by 9.99% to $8.3 million in 2016, then tumbled by 41.63% to $4.8 million in 2017, then soared by 1439.1% to $74.4 million in 2018.
  • Per Business Quant, the three most recent readings for SGRY's Asset Writedowns and Impairment are $74.4 million (Q4 2018), $11.6 million (Q3 2018), and $8.2 million (Q2 2018).